Vivo Capital, LLC - KINIKSA PHARMACEUTICALS LTD ownership

KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 76 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Vivo Capital, LLC ownership history of KINIKSA PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2020$17,643,000
-39.9%
1,151,6220.0%1.02%
-51.5%
Q2 2020$29,343,000
+149.7%
1,151,622
+51.7%
2.10%
+97.7%
Q1 2020$11,750,000
+2.9%
759,050
-10.0%
1.06%
-0.6%
Q2 2019$11,421,000
-25.0%
843,4780.0%1.07%
-29.6%
Q1 2019$15,233,000
+104.7%
843,478
+218.4%
1.52%
+59.9%
Q4 2018$7,440,000
+10.2%
264,8780.0%0.95%
+39.5%
Q3 2018$6,754,000
+109.2%
264,878
+42.4%
0.68%
+63.7%
Q2 2018$3,228,000186,0730.42%
Other shareholders
KINIKSA PHARMACEUTICALS LTD shareholders Q1 2020
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 2,474,561$42,983,1255.17%
Rubric Capital Management LP 3,077,449$53,455,2892.00%
Parkman Healthcare Partners LLC 509,810$8,855,4001.62%
TANG CAPITAL MANAGEMENT LLC 600,000$10,422,0001.47%
AlphaCentric Advisors LLC 110,000$1,910,7001.08%
Lion Point Capital, LP 130,691$2,270,1031.01%
RICE HALL JAMES & ASSOCIATES, LLC 650,366$11,296,8570.72%
ESSEX INVESTMENT MANAGEMENT CO LLC 185,853$3,228,2670.53%
ADVISORY RESEARCH INC 204,098$3,545,1820.49%
Jackson Creek Investment Advisors LLC 65,607$1,1400.48%
View complete list of KINIKSA PHARMACEUTICALS LTD shareholders